Hypocholesterolaemic activity of suloctidil: double-blind, crossover short-term and long-term treatment trial

Summary Two studies were carried out inpatients with primary hyperlipidaemia to investigate the effect of suloctidil (200 mg 3-times daily) on serum cholesterol levels and other lipidaemic variables. The first study was a double-blind, crossover comparison of suloctidil and placebo in 23 patients. P...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Current medical research and opinion 1984, Vol.9 (3), p.147-152
Hauptverfasser:	Chieffo, C., Postiglione, A., Tritto, C., Mancini, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	antilipaemic agents Body Weight Cholesterol - blood Clinical Trials as Topic Double-Blind Method Drug Evaluation Humans hyperlipidaemia Hyperlipidemias - drug therapy Propanolamines - therapeutic use Random Allocation Suloctidil Suloctidil - therapeutic use Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!